IL325213A - הרכבים ושיטות לאפנון של ביטוי טאו - Google Patents

הרכבים ושיטות לאפנון של ביטוי טאו

Info

Publication number
IL325213A
IL325213A IL325213A IL32521325A IL325213A IL 325213 A IL325213 A IL 325213A IL 325213 A IL325213 A IL 325213A IL 32521325 A IL32521325 A IL 32521325A IL 325213 A IL325213 A IL 325213A
Authority
IL
Israel
Prior art keywords
compositions
methods
tau expression
modulating tau
modulating
Prior art date
Application number
IL325213A
Other languages
English (en)
Original Assignee
Denali Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Denali Therapeutics Inc filed Critical Denali Therapeutics Inc
Publication of IL325213A publication Critical patent/IL325213A/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/315—Phosphorothioates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/32—Chemical structure of the sugar
    • C12N2310/323—Chemical structure of the sugar modified ring structure
    • C12N2310/3231—Chemical structure of the sugar modified ring structure having an additional ring, e.g. LNA, ENA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/33—Chemical structure of the base
    • C12N2310/334—Modified C
    • C12N2310/3341—5-Methylcytosine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/34—Spatial arrangement of the modifications
    • C12N2310/341—Gapmers, i.e. of the type ===---===

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL325213A 2023-06-22 2025-12-08 הרכבים ושיטות לאפנון של ביטוי טאו IL325213A (he)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202363509696P 2023-06-22 2023-06-22
PCT/US2024/034923 WO2024263852A2 (en) 2023-06-22 2024-06-21 Compositions and methods for modulating tau expression

Publications (1)

Publication Number Publication Date
IL325213A true IL325213A (he) 2026-02-01

Family

ID=93936381

Family Applications (1)

Application Number Title Priority Date Filing Date
IL325213A IL325213A (he) 2023-06-22 2025-12-08 הרכבים ושיטות לאפנון של ביטוי טאו

Country Status (3)

Country Link
AU (1) AU2024313057A1 (he)
IL (1) IL325213A (he)
WO (1) WO2024263852A2 (he)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2019233612A1 (en) * 2018-03-13 2020-09-10 Janssen Pharmaceutica Nv Modified oligonucleotides for use in treatment of tauopathies
KR20240067943A (ko) * 2021-09-24 2024-05-17 알닐람 파마슈티칼스 인코포레이티드 미소관 연관 단백질 타우(MAPT) iRNA 제제 조성물 및 이의 사용 방법
AU2023298154A1 (en) * 2022-07-01 2024-12-19 Denali Therapeutics Inc. Transferrin receptor binding molecule conjugates for delivery of oligonucleotides to cells

Also Published As

Publication number Publication date
AU2024313057A1 (en) 2025-10-30
WO2024263852A2 (en) 2024-12-26
WO2024263852A3 (en) 2025-05-15

Similar Documents

Publication Publication Date Title
EP3920918A4 (en) METHODS AND COMPOSITIONS FOR MODULATION OF SPLICING
IL287398A (he) שיטות ותכשירים לאפנון חיבור ותרגום
IL290595A (he) הרכבים ושיטות לאפנון איחוי וביטוי חלבון
EP3920915A4 (en) METHODS AND COMPOSITIONS FOR MODULATING SPLICE
EP3920919A4 (en) METHODS AND COMPOSITIONS FOR MODULATING SPLICE
EP3920916A4 (en) METHODS AND COMPOSITIONS FOR MODULATING SPLICE
EP4125434A4 (en) COMPOSITIONS AND METHODS FOR MODULATING THE INFLAMMATORY RESPONSE
EP3920920A4 (en) METHODS AND COMPOSITIONS FOR MODULATING SPLICE
EP3921311A4 (en) METHODS AND COMPOSITIONS FOR MODULATING SPLICE
IL307625A (he) תרכובות ושיטות לווסת ביטוי pnpla3
EP4127172A4 (en) Methods and compositions for restoring STMN2 levels
EP3920910A4 (en) METHODS AND COMPOSITIONS FOR MODULATION OF SPLICING
EP3938352A4 (en) METHODS AND COMPOSITIONS FOR MODULATING SPLICE
EP3931336A4 (en) COMPOSITIONS AND METHODS FOR TREATMENT OF LAMINOPATHIES
IL290958A (he) שיטות ותכשירים למודולציה של הזדקנות תאית
SG11202103316TA (en) Methods and compositions for modulation of tau proteins
EP4096675A4 (en) COMPOSITIONS AND METHODS FOR TREATING LONG COVID
CA3263582A1 (en) COMPOSITIONS AND METHODS FOR INDUCING FERROPTOSE
IL325213A (he) הרכבים ושיטות לאפנון של ביטוי טאו
EP4125978A4 (en) COMPOSITIONS AND METHODS FOR MODULATING THE INFLAMMATORY RESPONSE
CA3295995A1 (en) Compositions and methods for modulating tau expression
EP4041207A4 (en) COMPOSITIONS AND METHODS FOR INHIBITING COLLAGEN LOSS
AU2020407501A1 (en) Methods and compositions for evaluating and treating fibrosis
HK40099806A (en) Compositions and methods for modulating pnpla3 expression
CA3285540A1 (en) Compositions and methods for modulating sptlc1